| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/19/2009 | US20090075984 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 03/19/2009 | US20090075983 Novel Diazabicycloalkane Derivatives and Their Medical Use |
| 03/19/2009 | US20090075982 Piperazine compounds |
| 03/19/2009 | US20090075981 INHIBITORS OF p38 |
| 03/19/2009 | US20090075980 Pyrazolopyridines and Analogs Thereof |
| 03/19/2009 | US20090075979 CETP Inhibitors |
| 03/19/2009 | US20090075978 Substituted propiolic acid amides and their use for producing drugs |
| 03/19/2009 | US20090075977 Deuterium-enriched mk0974 |
| 03/19/2009 | US20090075976 Association between an anti-atherothrombotic and an angiotensin-converting enzyme inhibitor |
| 03/19/2009 | US20090075975 Arylsulfonamides and uses related thereto |
| 03/19/2009 | US20090075974 Agent for prophylaxis and treatment of pancreatitis |
| 03/19/2009 | US20090075973 Benzo-fused heterocycles |
| 03/19/2009 | US20090075972 Use of Midostaurin for Treating Gastrointestinal Stromal Tumors |
| 03/19/2009 | US20090075971 Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same |
| 03/19/2009 | US20090075970 Thieno-and furo-pyrimidine modulators of the histamine H4 receptor |
| 03/19/2009 | US20090075969 Deuterium-enriched doripenem |
| 03/19/2009 | US20090075968 CETP inhibitors |
| 03/19/2009 | US20090075967 Deuterium-enriched ceftriaxone |
| 03/19/2009 | US20090075966 Deuterium-enriched tazobactam |
| 03/19/2009 | US20090075965 Deuterium-enriched amoxicilin |
| 03/19/2009 | US20090075964 Fragrance compositions and other compositions which contain naturally occurring substances found in corals |
| 03/19/2009 | US20090075963 Transdermal hormone spray |
| 03/19/2009 | US20090075962 Growth stimulant compositions |
| 03/19/2009 | US20090075961 Testosterone Oral Dosage Formulations And Associated Methods |
| 03/19/2009 | US20090075960 Method of treating gaucher disease |
| 03/19/2009 | US20090075959 Deuterium-enriched ciclesonide |
| 03/19/2009 | US20090075958 Clobetasol propionate shampoos for the treatment of seborrheic dermatitis of the scalp |
| 03/19/2009 | US20090075957 Xanthohumol compositions and methods of using same |
| 03/19/2009 | US20090075956 Genetic Risk Assessment in Heart Failure: Impact of the Genetic Variation of NOS3 |
| 03/19/2009 | US20090075955 Therapeutic regimens for the treatment of immunoinflammatory disorders |
| 03/19/2009 | US20090075954 Soft anticholinergic esters |
| 03/19/2009 | US20090075953 Deuterium-enriched ed-71 |
| 03/19/2009 | US20090075952 Nitroderviatives as drugs for diseases having an inflammatory basis |
| 03/19/2009 | US20090075951 Methods and Reagents for the Treatment of Inflammatory Disorders |
| 03/19/2009 | US20090075950 Dosage Forms Containing A PPI, NSAID And A Buffer |
| 03/19/2009 | US20090075949 such as dabigatran etexilate, rivaroxaban, Ximelagatran, bivalirudin, Apixaban |
| 03/19/2009 | US20090075948 Compositions and methods for regulating cellular protection |
| 03/19/2009 | US20090075947 Deuterium-enriched fospropofol |
| 03/19/2009 | US20090075946 Novel triterpenic acid derivative and preparation for external application for skin comprising the same |
| 03/19/2009 | US20090075945 Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-selective antineoplastic agents |
| 03/19/2009 | US20090075944 Deuterium-enriched ibandronate |
| 03/19/2009 | US20090075943 Combretastatin Analogs with Tubulin Binding Activity |
| 03/19/2009 | US20090075942 Deuterium-enriched fosamprenavir |
| 03/19/2009 | US20090075941 Treating neoplasms |
| 03/19/2009 | US20090075940 Deuterium-enriched risedronate |
| 03/19/2009 | US20090075939 Novel HIV reverse transcriptase inhibitors |
| 03/19/2009 | US20090075938 Treatment of duchenne muscular dystrophy |
| 03/19/2009 | US20090075937 Lhrh antagonists for the treatment of lower urinary tract symptoms |
| 03/19/2009 | US20090075936 Proteasome inhibitors and methods of using the same |
| 03/19/2009 | US20090075933 Cytocompatible alginate gels |
| 03/19/2009 | US20090075932 METHOD OF SELECTIVELY INHIBITING PKCiota |
| 03/19/2009 | US20090075931 isotope exchanged capecitabine, used for the treatment of metastatic breast cancer; anticarcinogenic agents |
| 03/19/2009 | US20090075930 for treating leukemia |
| 03/19/2009 | US20090075929 Ig20 splice variants therapeutics for cancer |
| 03/19/2009 | US20090075928 G-QUARTET OLIGONUCLEOTIDES THAT TARGET HYPOXIA-INDUCIBLE FACTOR 1-a (HIF1a ) |
| 03/19/2009 | US20090075927 Sweet taste receptors |
| 03/19/2009 | US20090075926 Method for identifying and manipulating cells |
| 03/19/2009 | US20090075925 Methods and Compositions Related to APOBEC-1 Expression |
| 03/19/2009 | US20090075924 antisense therapy; for diagnosis and treatment of atherosclerosis, hypercholesterolemia, or coronary artery disease |
| 03/19/2009 | US20090075923 Methods of treatment of renal disease |
| 03/19/2009 | US20090075922 Nucleic Acid Ligands Which Bind to Hepatocyte Growth Factor/Scatter Factor (HGF/SF) or its Receptor c-met |
| 03/19/2009 | US20090075921 Bone/joint disease sensitivity gene and use thereof |
| 03/19/2009 | US20090075920 Deuterium-enriched decitabine |
| 03/19/2009 | US20090075919 Anti-neoplastic compositions comprising extracts of black cohosh |
| 03/19/2009 | US20090075918 Veterinarian composition comprising an organic salt of levamisole in combination with at least one avermectine and/or milbemycine |
| 03/19/2009 | US20090075917 Deuterium-enriched telithromycin |
| 03/19/2009 | US20090075916 Use of Macrolide Derivatives for Treating Acne |
| 03/19/2009 | US20090075915 6,11-bicyclolides: bridged biaryl macrolide derivatives |
| 03/19/2009 | US20090075914 Deuterium-enriched odiparcil |
| 03/19/2009 | US20090075913 Glycoside having 4-methylergost-7-en-3-ol skeleton and hyperglycemia improving agent |
| 03/19/2009 | US20090075912 Use of Timosaponin BII in the Preparation Of A Medicament or Product for the Prevention and Treatment of Stroke |
| 03/19/2009 | US20090075911 Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring |
| 03/19/2009 | US20090075910 Deuterium-enriched fondaparinux |
| 03/19/2009 | US20090075909 Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds |
| 03/19/2009 | US20090075908 Agent For Strengthening Calcium Containing Tissue and Use Thereof |
| 03/19/2009 | US20090075902 Inhibiting the signs of aging by inhibiting nf-kappa b activation |
| 03/19/2009 | US20090075900 Therapeutic agent for motor neuron disease |
| 03/19/2009 | US20090075889 Iren protein, its preparation and use |
| 03/19/2009 | US20090075888 Cardiovascular and Brain Cell Therapy Using Intracellular Ryanodine Receptor Modulation by the Estrogen Receptor Beta |
| 03/19/2009 | US20090075873 Gastrin compositions and formulations, and methods of use and preparation |
| 03/19/2009 | US20090075868 Synthetic peptide materials for joint reconstruction, repair and cushioning |
| 03/19/2009 | US20090075867 Triazine compounds and compositions thereof for the treatment of cancers |
| 03/19/2009 | US20090075864 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 03/19/2009 | US20090075861 Systems and methods of removing and managing heavy metals |
| 03/19/2009 | US20090075860 Transdermal absorption enhancer |
| 03/19/2009 | US20090075842 Neoglycorandomization and digitoxin analogs |
| 03/19/2009 | US20090075839 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigents and uses thereof |
| 03/19/2009 | US20090075819 Indanyl- and Tetrahydronaphtyl-amino-thiourea Compounds for Combating Animal Pests |
| 03/19/2009 | US20090075376 METHODS OF INHIBITING TUMOR CELL PROLIFERATION WITH FOXM1 siRNA |
| 03/19/2009 | US20090075369 Angiostatin Fragments and Method of Use |
| 03/19/2009 | US20090075327 Methods for improving secondary metabolite production in fungi |
| 03/19/2009 | US20090075302 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090075279 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090075278 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090075268 Glycoprotein for use in the treatment of hearing loss defects; Inner Ear Supporting Cell Antigen (IESCA) reactive with an autoantibody associated with AISNHL |
| 03/19/2009 | US20090074891 Combretum laurifolium mart. extract and methods of extracting and using such extract |
| 03/19/2009 | US20090074890 Substituted Triazoles as Sodium Channel Blockers |
| 03/19/2009 | US20090074887 For control of phytopathogenic fungi; synergistic |
| 03/19/2009 | US20090074886 Gsk-3 inhibitors |
| 03/19/2009 | US20090074885 Reversible Hydrophobic Modification of Drugs for Improved Delivery to Cells |